NYSEAMERICAN:CCEL Cryo-Cell International (CCEL) Stock Price, News & Analysis $7.27 -0.04 (-0.55%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest About Cryo-Cell International Stock (NYSEAMERICAN:CCEL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CCEL alerts:Sign Up Key Stats Today's Range$7.20▼$8.1050-Day Range N/A52-Week Range$3.67▼$9.50Volume98,093 shsAverage Volume9,584 shsMarket Capitalization$58.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.Read More… The real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Cryo-Cell International Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks19th Percentile Overall ScoreCCEL MarketRank™: Cryo-Cell International scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cryo-Cell International.Read more about Cryo-Cell International's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cryo-Cell International is -6.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cryo-Cell International is -6.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.27% of the float of Cryo-Cell International has been sold short.Short Interest Ratio / Days to CoverCryo-Cell International has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cryo-Cell International has recently decreased by 29.27%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCryo-Cell International does not currently pay a dividend.Dividend GrowthCryo-Cell International does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.27% of the float of Cryo-Cell International has been sold short.Short Interest Ratio / Days to CoverCryo-Cell International has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cryo-Cell International has recently decreased by 29.27%, indicating that investor sentiment is improving significantly. News and Social Media1.9 / 5News Sentiment0.50 News SentimentCryo-Cell International has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Cryo-Cell International this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cryo-Cell International insiders have not sold or bought any company stock.Percentage Held by Insiders33.80% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.44% of the stock of Cryo-Cell International is held by institutions.Read more about Cryo-Cell International's insider trading history. Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Email Address CCEL Stock News HeadlinesCRYO-CELL International, Inc. trading resumesOctober 31 at 8:59 AM | markets.businessinsider.comCRYO-CELL International, Inc. trading halted, volatility trading pauseOctober 31 at 8:59 AM | markets.businessinsider.comThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. October 31, 2024 | Porter & Company (Ad)Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash DividendOctober 30 at 4:50 PM | finance.yahoo.comCompany seeks arbitration against Duke University claiming $100M in damagesOctober 23, 2024 | bizjournals.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial ResultsOctober 15, 2024 | businesswire.comCryo-Cell International Inc CCELJuly 19, 2024 | morningstar.comCryo-Cell International IncMay 22, 2024 | morningstar.comSee More Headlines CCEL Stock Analysis - Frequently Asked Questions How were Cryo-Cell International's earnings last quarter? Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) issued its quarterly earnings data on Tuesday, October, 15th. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.11. The company had revenue of $8.07 million for the quarter. Cryo-Cell International had a negative net margin of 29.38% and a negative trailing twelve-month return on equity of 49.94%. How do I buy shares of Cryo-Cell International? Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cryo-Cell International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Meta Platforms (META), Alimera Sciences (ALIM), Catalyst Biosciences (CBIO), iClick Interactive Asia Group (ICLK), NVIDIA (NVDA), AcelRx Pharmaceuticals (ACRX) and Aspen Group (ASPU). Company Calendar Last Earnings10/15/2024Today10/31/2024Fiscal Year End11/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealthcare Current SymbolNYSEAMERICAN:CCEL CUSIPN/A CIK862692 Webwww.cryo-cell.com Phone(813) 749-2100Fax813-855-4745Employees90Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,520,000.00 Net Margins-29.38% Pretax Margin-40.01% Return on Equity-49.94% Return on Assets6.28% Debt Debt-to-Equity RatioN/A Current Ratio0.52 Quick Ratio0.49 Sales & Book Value Annual Sales$31.34 million Price / Sales1.86 Cash Flow$0.74 per share Price / Cash Flow9.75 Book Value($1.33) per share Price / Book-5.45Miscellaneous Outstanding Shares8,060,000Free Float5,337,000Market Cap$58.44 million OptionableNot Optionable Beta0.45 Social Links 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NYSEAMERICAN:CCEL) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryo-Cell International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.